Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Harvard Business School
Citi
McKinsey
Julphar
Express Scripts
Baxter
Covington
US Department of Justice
McKesson

Generated: August 23, 2017

DrugPatentWatch Database Preview

CAPECITABINE Drug Profile

« Back to Dashboard

Which patents cover Capecitabine, and what generic Capecitabine alternatives are available?

Capecitabine is a drug marketed by Amneal Pharms, Mylan Pharms Inc, Teva Pharms Usa, Shilpa Medicare Ltd, West-ward Pharms Int, and Accord Hlthcare. and is included in six NDAs.

The generic ingredient in CAPECITABINE is capecitabine. There are twenty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the capecitabine profile page.

Summary for Tradename: CAPECITABINE

Patents:0
Applicants:6
NDAs:6
Suppliers / Packagers: see list12
Bulk Api Vendors: see list78
Clinical Trials: see list1,149
Patent Applications: see list7,054
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CAPECITABINE at DailyMed

Pharmacology for Tradename: CAPECITABINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms
CAPECITABINE
capecitabine
TABLET;ORAL204741-001Feb 28, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Shilpa Medicare Ltd
CAPECITABINE
capecitabine
TABLET;ORAL207456-001Dec 12, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
CAPECITABINE
capecitabine
TABLET;ORAL090943-002Aug 8, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
CAPECITABINE
capecitabine
TABLET;ORAL202593-002Apr 23, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Shilpa Medicare Ltd
CAPECITABINE
capecitabine
TABLET;ORAL207456-002Dec 12, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
AstraZeneca
Boehringer Ingelheim
Novartis
UBS
McKinsey
Cerilliant
Cantor Fitzgerald
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot